Search Results 381-390 of 10809 for colchicine

1. Publications - Christopher V. DeSimone, M.D., Ph.D. - Mayo Clinic

   Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized ...

2. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml

3. Mexiletine (oral route) - Side effects & dosage - Mayo Clinic

   Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

4. Publications - Julie A. Khoury, M.D. - Mayo Clinic

   Panrudkevich AH, Jones FJS, Shouman K, Klein CJ, Dyck PJB, Berini SE, Lamb CJ, Jacobi J, Staff NP, Dubey D, Engelstad JK, Martinez-Thompson JM, Grogan M, ...

5. Pediatrics Clinical Trials - Medical Professionals - Mayo Clinic

   The purpose of this study is to demonstrate 1) feasibility of digital biomarker assessment using wearable in children with solid tumors who undergo surgery ...

6. Cyclopentolate (ophthalmic route) - Side effects & dosage - Mayo Clinic

   This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Solution. Back to top ...

7. Oncology (Medical) - Clinical trials - Mayo Clinic

   This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

8. BT – L-CsA – 301 – SLT: A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial To Demonstrate The Efficacy And Safety Of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered Via The PARI Investigational EFlow® Device Plus Standard Of Care Versus Standard Of Care Alone In The Treatment Of Chronic Lung Allograft Syndrome / Bronchiolitis Obliterans Syndrome In Patients Post Single Lung Transplantation - Mayo Clinic

   BT – L-CsA – 301 – SLT: A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial To Demonstrate The Efficacy And Safety Of Liposomal ...

9. Transition To KPL-387 Monotherapy Dosing & Administration Study - Mayo Clinic

   ... colchicine, and/or glucocorticoids or an IL-1 pathway inhibitor (anakinra or rilonacept). Key Exclusion Criteria: * Has a diagnosis of pericarditis that is ...

10. Oxaprozin (oral route) - Side effects & dosage - Mayo Clinic

    Appropriate studies have not been performed on the relationship of age to the effects Coxanto® and Daypro® to treat juvenile rheumatoid arthritis in children ...